K
K. H. Yu
Researcher at The Chinese University of Hong Kong
Publications - 15
Citations - 963
K. H. Yu is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Nasopharyngeal carcinoma. The author has an hindex of 10, co-authored 15 publications receiving 900 citations.
Papers
More filters
Journal ArticleDOI
Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
Anthony T.C. Chan,Sing Fai Leung,Roger K.C. Ngan,Peter M.L. Teo,W.H. Lau,Wing Hong Kwan,Edwin P. Hui,Harry H.Y. Yiu,Winnie Yeo,Filly Cheung,K. H. Yu,K. W. Chiu,Danny T.M. Chan,Tony Mok,Stephen Yau,Kam-tong Yuen,Frankie Mo,Maria M.P. Lai,Brigette B.Y. Ma,Michael K.M. Kam,Thomas W.T. Leung,Philip J. Johnson,Peter H.K. Choi,Benny Zee +23 more
TL;DR: The regimen of weekly concurrent CRT is a promising standard treatment strategy for locoregionally advanced nasopharyngeal carcinoma patients, and the difference in overall survival was statistically significantly in favor of concurrentCRT.
Journal ArticleDOI
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
Peter M.L. Teo,P. Yu,W. Y. Lee,Sing-fai Leung,Wing Hong Kwan,K. H. Yu,Peter H.K. Choi,Philip J. Johnson +7 more
TL;DR: The significant prognosticators in nasopharyngeal carcinoma are delineated after the advent of CT and should form the foundation of the modern stage classification for NPC.
Journal ArticleDOI
Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
Anthony T.C. Chan,Brigette B.Y. Ma,Y.M. Dennis Lo,Sing F. Leung,Wing Hong Kwan,Edwin P. Hui,Tony Mok,Michael Kam,Lisa S. Chan,Samuel K.W. Chiu,K. H. Yu,Kin Yin Cheung,Karen Lai,Maria Lai,Frankie Mo,Winnie Yeo,Ann D. King,Philip J. Johnson,Peter M.L. Teo,Benny Zee +19 more
TL;DR: Serial plasma EBV DNA provides a noninvasive method of monitoring response in NPC and resulted in excellent local tumor control.
Journal ArticleDOI
Strong Immunohistochemical Expression of Vascular Endothelial Growth Factor Predicts Overall Survival in Head and Neck Squamous Cell Carcinoma
Gary Tse,Anthony W.H. Chan,K. H. Yu,Ann D. King,Ka-Tak Wong,George G. Chen,Raymond K. Y. Tsang,Amy B.W. Chan +7 more
TL;DR: Both univariate and multivariate survival analysis showed that advanced T stage, nodal metastasis, and strong VEGF intensity were independent adverse predictors for overall and disease-free survival.
Journal ArticleDOI
T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma
Ann D. King,C. K. Keung,K. H. Yu,Frankie Mo,Kunwar S.S. Bhatia,David K.W. Yeung,Gary Tse,Alexander C. Vlantis,Anil T. Ahuja +8 more
TL;DR: T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response and awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.